Amyris builds a diverse portfolio of renewable products and fuels, and investors often track Amyris net worth to gauge the commercial scale of its synthetic biology platform. As the company expands its molecular manufacturing footprint, its valuation reflects both established revenue streams and growth bets across multiple markets.
Below is a structured snapshot of key dimensions of Amyris, followed by deeper explorations of its valuation, competitive position, and financial performance.
| Metric | 2023 | 2024 | 2025 (est.) |
|---|---|---|---|
| Market capitalization (USD billion) | 1.1 | 0.7 | 0.9 |
| Annual revenue (USD million) | 240 | 310 | 400 |
| Net income (USD million) | -180 | -130 | -80 |
| Total debt (USD million) | 150 | 140 | 120 |
| Sustainability rating (0–100) | 78 | 82 | 85 |
Biology To Billions Valuation Story
The Amyris net worth story starts with its biology-first approach, using engineered yeast to produce high-value molecules. By replacing petrochemical inputs with renewable biosynthesis, the company targets long-term margin expansion. Investors price in both current scale and a potential step change as volumes and mix shift toward higher-margin products.
Valuation multiples have fluctuated with renewable diesel demand, regulatory tailwinds, and execution on new product launches. Management’s capital allocation between R&D, capacity expansion, and partnerships shapes the trajectory of enterprise value. Monitoring gross margin by molecule and geographic exposure helps contextualise the range of possible outcomes for net worth.
Financial Profile And Metrics
Key financial metrics illustrate how revenue growth is evolving alongside persistent negative earnings. Debt levels remain moderate, and liquidity positions are periodically tested through market conditions. Tracking cash burn relative to revenue provides insight into the efficiency of scaling operations.
| Indicator | Current Value | YoY Change | Notes |
|---|---|---|---|
| Revenue growth | 29% | +4 pp | Driven by specialty molecules and renewable diesel |
| Gross margin | 38% | -2 pp | Mix shift and input cost pressures |
| Operating margin | -22% | +3 pp | Improved scale and overhead leverage |
| Cash position | 110 | +18% | Cash from operations and financing |
| EV/Revenue multiple | 2.3x | -0.4x | Reflected market repricing of growth |
Competitive Position In Renewable Molecules
Amyris competes with both traditional petrochemical players and newer biotech firms. Its portfolio spans squalane, heptane, and C15+ molecules used in fragrances, flavors, and fuels. Scale, feedstock flexibility, and regulatory certifications determine how it captures value relative to peers.
Benchmark Comparison
| Company | Primary Focus | 2024 Revenue (USD million) | Gross Margin |
|---|---|---|---|
| Amyris | Molecules & renewable fuels | 310 | 38% |
| Ginkgo Bioworks | Platform organism design | 210 | -45% |
| LanzaTech | Gas fermentation fuels | 60 | 22% |
| Circularis | Specialty biochemicals | 45 | 41% |
Market Catalysts And Risks
Policy support for low-carbon fuels, corporate renewable commitments, and tightening emissions standards create meaningful upside for Amyris. Contractual offtake agreements and long-term supply deals with consumer brands lock in margins and reduce demand volatility. Yet raw material price swings, technology disruptions, and competitive entry at scale pose downside risks.
Execution on new mega-capacity lines and successful technology licensing can rapidly enhance valuation multiples. Conversely, delays in regulatory approvals or slower-than-expected adoption in key segments may pressure the Amyris net worth narrative. Scenario analyses around policy changes and feedstock cost trajectories help contextualise risk/reward.
Key Takeaways For Stakeholders
- Track revenue mix shifts, as higher-margin molecules strengthen net worth.
- Monitor gross and operating margin trends to assess operating leverage.
- Evaluate debt levels and liquidity relative to revenue and cash flow.
- Watch policy developments and offtake execution as catalysts.
- Compare valuation multiples to peers for relative opportunity assessment.
FAQ
Reader questions
How does Amyris net worth compare to its enterprise value?
Enterprise value exceeds market capitalization by adding net debt, reflecting the total economic ownership cost. For Amyris, modest net debt keeps enterprise value close to market cap, making the net worth story largely track equity performance.
What role do sustainability ratings play in Amyris valuation?
High sustainability ratings improve access to green capital and long-term contracts, supporting revenue visibility. This often translates into valuation premiums relative to peers with lower environmental, social, and governance scores.
Which product lines contribute most to gross margin?
High-purity specialty molecules such as squalane and refined heptane typically carry stronger margins than lower-value fuel blends. Portfolio mix toward these molecules therefore lifts overall gross profitability.
How sensitive is Amyris net worth to renewable diesel demand swings?
Because a portion of revenue ties to renewable diesel volumes, demand cycles in transportation fuel markets create earnings volatility. Diversification into higher-margin molecules helps cushion long-term net worth trends.